Key result
Riemann-Navier mapping protocol details methodological calibration for computational fluid dynamics without clinical endpoints.
Establishes an audit-first, non-circular mapping protocol and calibration phase between Riemann-side and Navier-Stokes-side lenses using synthetic vessel CFD data.
Should not inform clinical practice; extends CFD reliability via audit-first non-circular calibration for future vessel modeling research.
This record is a Concept Lock (v0.1): it freezes a non-circular, audit-first mapping protocol betweena Riemann-side (spectral / oscillatory-superposition) lens and a Navier–Stokes-side (transport) lens. Scope (NO OVERCLAIM):- Not a proof claim (no RH claim; no Navier–Stokes regularity claim).- Not a performance claim.- Not clinical advice, patient-specific guidance, or treatment recommendations.- Not an equivalence claim between number theory and fluid dynamics.Dual-use boundary: NO military, NO surveillance, NO coercion. Frozen core (v0.1):- Primary module: M2 (Gate + Responsibility layer + Audit state {PASS, FAIL, INCOMPLETE}).- Crosspoint invariants: A_inv (Crosspoint A), B_inv (Crosspoint B), and C_rule (matching).- Coherence gate: G_coh using coh_score with named threshold coh_min (definition-only; no calibration in v0.1).- RISK-3 kill-switch: the SAME frozen M2 object must be instantiated on both sides. Files included:- Canonical text (ASCII): CONCEPT_LOCK_Riemann-Navier_Mapping_Protocol_v0.1_ASCII.txt- View copy (PDF): CONCEPT_LOCK_Riemann-Navier_Mapping_Protocol_v0.1_NatureStyle_LiberationSans.pdf- Figure: Fig_CL1_Riemann-Navier_Concept_Lock_Map_v1.0.png- INSTALL_ME: INSTALL_ME_Riemann-Navier_Mapping_Protocol_v0.1_ConceptLock_ASCII.txt Template provenance:- QCRM v2 (Suga): 10.5281/zenodo.17816492 References:[1] QCRM v2: 10.5281/zenodo.17816492[2] Audit-First Haemodynamic Navier–Stokes CFD I (Route A): 10.5281/zenodo.18799728[3] GQMI: MedAI Trust-Graph (v0.2.3): 10.5281/zenodo.18757326
No takes yet. Share an insight, caveat, or question.
Hisashi Suga (2026) studied this question. No clinical trial or clinical evidence is presented in this paper; it describes a methodological calibration protocol for a computational fluid dynamics mapping technique, not involving clinical endpoints or patient data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: